PEDRO RODRIGUEZ: Open Payments
NPI 1821708256 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 19 payments from 9 companies in 2025. Trend: 2023 $63 · 2024 $87 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 7 | $190 |
| AstraZeneca Pharmaceuticals LP | 4 | $115 |
| TerSera Therapeutics LLC | 2 | $56 |
| Genentech USA, Inc. | 1 | $34 |
| BeOne Medicines USA, Inc. | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Incyte Corporation | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| PFIZER INC. | 1 | $23 |
Products named: AUSTEDO XR, Zoladex, ENHERTU, Tecentriq, TEVIMBRA, LYNPARZA, DATROWAY, MONJUVI.
Industry payments across FL — which companies pay providers there.
